Item does not contain fulltextINTRODUCTION: Fatigue is a frequent problem during and after cancer treatment. We investigated different courses of fatigue from pre-diagnosis, through therapy, to long-term survivorship and evaluated potential implications on long-term quality of life (QoL). METHODS: Breast cancer patients diagnosed in 2001-2005 were recruited in a case-control study in Germany (MARIE). At follow-up in 2009 (median 5.8 years, MARIEplus), patients self-reported current fatigue and QoL status using validated questionnaires (FAQ, EORTC QLQ-C30). In addition, survivors retrospectively rated fatigue levels pre-diagnosis, during different treatment phases, and 1 year post-surgery. Our analyses included 1,928 disease-free cancer surv...
Purpose: Prolonged and disabling fatigue is prevalent after cancer treatment, but the early natural ...
OBJECTIVE To examine fatigue and quality of life (QOL) in breast cancer patients undergoing chemo...
PURPOSE: Severe fatigue after treatment of ductal carcinoma in situ (DCIS) has not been studied befo...
INTRODUCTION: Fatigue is a frequent problem during and after cancer treatment. We investigated diffe...
Item does not contain fulltextBACKGROUND: In this study, the authors examined the influence of prior...
BACKGROUND: In this study, the authors examined the influence of prior treatment on the course of fa...
Item does not contain fulltextOBJECTIVE: Fatigue is among the most distressing symptoms across the b...
Simple Summary The number of long-term breast cancer survivors is increasing. Earlier research showe...
Item does not contain fulltextBACKGROUND: We investigated whether fatigue is a persistent problem, a...
Background Fatigue is the most common and persistent symptom among women in the first five years aft...
Introduction. Fatigue is the most common and stressful side effect of cancer and its treatments and ...
Objectives: Fatigue is the most frequently reported symptom experienced by cancer patients and has a...
Severe fatigue occurs in one in four breast cancer survivors (BCS). Quality of life (QOL) and psycho...
Item does not contain fulltextPURPOSE: Cancer survivors commonly experience fatigue, related to dise...
BackgroundFatigue is a common and expected side effect of cancer treatment. However, the majority of...
Purpose: Prolonged and disabling fatigue is prevalent after cancer treatment, but the early natural ...
OBJECTIVE To examine fatigue and quality of life (QOL) in breast cancer patients undergoing chemo...
PURPOSE: Severe fatigue after treatment of ductal carcinoma in situ (DCIS) has not been studied befo...
INTRODUCTION: Fatigue is a frequent problem during and after cancer treatment. We investigated diffe...
Item does not contain fulltextBACKGROUND: In this study, the authors examined the influence of prior...
BACKGROUND: In this study, the authors examined the influence of prior treatment on the course of fa...
Item does not contain fulltextOBJECTIVE: Fatigue is among the most distressing symptoms across the b...
Simple Summary The number of long-term breast cancer survivors is increasing. Earlier research showe...
Item does not contain fulltextBACKGROUND: We investigated whether fatigue is a persistent problem, a...
Background Fatigue is the most common and persistent symptom among women in the first five years aft...
Introduction. Fatigue is the most common and stressful side effect of cancer and its treatments and ...
Objectives: Fatigue is the most frequently reported symptom experienced by cancer patients and has a...
Severe fatigue occurs in one in four breast cancer survivors (BCS). Quality of life (QOL) and psycho...
Item does not contain fulltextPURPOSE: Cancer survivors commonly experience fatigue, related to dise...
BackgroundFatigue is a common and expected side effect of cancer treatment. However, the majority of...
Purpose: Prolonged and disabling fatigue is prevalent after cancer treatment, but the early natural ...
OBJECTIVE To examine fatigue and quality of life (QOL) in breast cancer patients undergoing chemo...
PURPOSE: Severe fatigue after treatment of ductal carcinoma in situ (DCIS) has not been studied befo...